• From Biopsy to Breakthrough: Real-world Genomics in Early-Stage Oncology Trials

  • Apr 16 2025
  • Length: 22 mins
  • Podcast

From Biopsy to Breakthrough: Real-world Genomics in Early-Stage Oncology Trials

Listen for free

View show details

  • Summary

  • In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and the strategic shift toward real-time decision-making, this conversation is essential listening for anyone in translational medicine or clinical development.


    Website
    www.ConcertAI.com

    LinkedIn
    www.linkedin.com/company/concertai/

    Twitter
    www.twitter.com/concertai
    Show more Show less
Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about From Biopsy to Breakthrough: Real-world Genomics in Early-Stage Oncology Trials

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available